Expert review on global real-world vaccine effectiveness against SARS-CoV-2

Author:

Chuenkitmongkol Sunate1,Solante Rontgene2,Burhan Erlina3,Chariyalertsak Suwat4,Chiu Nan-Chang5,Do-Van Dung6ORCID,Husin Masliyana7ORCID,Hwang Kao-Pin8,Kiertiburanakul Sasisopin9,Kulkarni Prasad S.10,Lee Ping-Ing11,Lobo Rommel Crisenio12,Nghia Cao Huu13,Ong-Lim Anna14,Sivasampu Sheamini7ORCID,Suah Jing Lian7ORCID,Tok Peter Seah Keng7ORCID,Thwaites Guy15,

Affiliation:

1. National Vaccine Institute, Nonthaburi, Thailand

2. San Lazaro Hospital, Manila, Philippines

3. Faculty of Medicine Universitas Indonesia, RSUP Persahabatan, Jakarta, Indonesia

4. Faculty of Public Health, Chiang Mai University, Chiang Mai, Thailand

5. MacKay Memorial Hospital, Taipei, Taiwan

6. University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam

7. Institute for Clinical Research, National Institutes of Health, Ministry of Health, Selangor, Malaysia

8. China Medical University Children’s Hospital, Taichung, Taiwan

9. Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

10. Serum Institute of India Pvt Ltd, Pune, India

11. Department of Pediatrics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan

12. Philippine Children’s Medical Center, Manila, Philippines

13. Institute Pasteur, Ho Chi Minh City, Vietnam

14. College of Medicine, Philippine General Hospital, University of the Philippines, Manila, Philippines

15. Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam, and The Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, UK

Funder

AstraZeneca for medical

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Reference84 articles.

1. Johns Hopkins Coronavirus Resource Center. (n.d.). JHU CSSE COVID. Johns Hopkins University & Medicine. [cited 2022 Jun 14] Available from: https://coronavirus.jhu.edu/map.html

2. Ritchie H, Mathieu E, Rodés-Guirao L, et al. (2020) “Coronavirus Pandemic (COVID-19)”. Published online at OurWorldInDataorg. [cited 2022 Mar 5] Available from: https://ourworldindata.org/coronavirus

3. Cumulative confirmed COVID-19 cases per million people. [cited 2022 March 5] Available from: https://ourworldindata.org/explorers/coronavirus-data-explorer?zoomToSelection=true&time=2020-03-01.latest&facet=none&pickerSort=asc&pickerMetric=location&Metric=Confirmed±cases&Interval=Cumulative&Relative±to±Population=true&Color±by±test±positivity=false&country=USA~GBR~CAN~DEU~ITA~IND~HKG~CHN~MYS~SGP~THA~IDN~PHL~VNM~MMR~KHM

4. U.S. Centers for Disease Control and Prevention. COVID data tracker (Variant proportions). [cited 2022 Jun 14] Available from: https://covid.cdc.gov/covid-data-tracker/#variant-proportions

5. European Centre for Disease Prevention and Control. Implications of the emergence and spread of the SARS-CoV-2 variants of concern BA.4 and BA.5 for the EU/EEA. [cited 2022 Jun 14] Available from: https://www.ecdc.europa.eu/en/news-events/implications-emergence-spread-sars-cov-2-variants-concern-ba4-and-ba5

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3